SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-000639
Filing Date
2021-01-05
Accepted
2021-01-05 09:08:51
Documents
3
Period of Report
2021-01-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211614d1_8k.htm 8-K 17055
2 EXHIBIT 99.1 tm211614d1_ex99-1.htm EX-99.1 12526
3 GRAPHIC tm211614d1_ex99-1img01.jpg GRAPHIC 8035
  Complete submission text file 0001104659-21-000639.txt   41985
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 21504082
SIC: 2834 Pharmaceutical Preparations